Principal Financial Group Inc. decreased its position in shares of Heartland Express, Inc. ( NASDAQ:HTLD – Free Report ) by 10.0% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 204,320 shares of the transportation company’s stock after selling 22,628 shares during the period. Principal Financial Group Inc.’s holdings in Heartland Express were worth $2,509,000 at the end of the most recent reporting period. A number of other institutional investors also recently modified their holdings of HTLD. Nisa Investment Advisors LLC raised its position in Heartland Express by 64.6% in the 2nd quarter. Nisa Investment Advisors LLC now owns 2,565 shares of the transportation company’s stock valued at $32,000 after purchasing an additional 1,007 shares during the last quarter. CWM LLC raised its stake in shares of Heartland Express by 266.3% in the second quarter. CWM LLC now owns 2,729 shares of the transportation company’s stock worth $34,000 after acquiring an additional 1,984 shares during the last quarter. EntryPoint Capital LLC acquired a new position in shares of Heartland Express during the first quarter worth approximately $62,000. Hsbc Holdings PLC bought a new stake in shares of Heartland Express during the second quarter valued at approximately $166,000. Finally, Inspire Advisors LLC increased its holdings in shares of Heartland Express by 11.8% in the second quarter. Inspire Advisors LLC now owns 16,447 shares of the transportation company’s stock valued at $203,000 after purchasing an additional 1,732 shares in the last quarter. Institutional investors own 53.45% of the company’s stock. Analyst Ratings Changes Several research analysts have issued reports on the company. UBS Group reduced their price objective on Heartland Express from $13.00 to $12.00 and set a “neutral” rating on the stock in a report on Wednesday, October 30th. Barclays upped their price target on Heartland Express from $10.00 to $11.00 and gave the company an “underweight” rating in a research note on Wednesday, November 13th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $11.75. Heartland Express Price Performance Shares of HTLD stock opened at $12.37 on Friday. The firm’s 50 day moving average price is $11.79 and its two-hundred day moving average price is $11.92. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.17 and a current ratio of 1.17. Heartland Express, Inc. has a 52-week low of $9.63 and a 52-week high of $14.60. The stock has a market cap of $971.05 million, a PE ratio of -42.31 and a beta of 0.71. Heartland Express ( NASDAQ:HTLD – Get Free Report ) last posted its quarterly earnings results on Tuesday, October 29th. The transportation company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.11). Heartland Express had a negative net margin of 2.11% and a negative return on equity of 2.70%. The company had revenue of $259.86 million during the quarter, compared to analyst estimates of $268.35 million. During the same period last year, the company earned ($0.14) EPS. The business’s revenue for the quarter was down 11.9% compared to the same quarter last year. As a group, analysts forecast that Heartland Express, Inc. will post -0.38 EPS for the current year. Insider Activity In related news, CEO Michael J. Gerdin purchased 35,960 shares of the business’s stock in a transaction on Friday, November 8th. The shares were purchased at an average price of $11.97 per share, with a total value of $430,441.20. Following the completion of the purchase, the chief executive officer now owns 1,311,913 shares in the company, valued at $15,703,598.61. This represents a 2.82 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website . Also, major shareholder Ann S. Gerdin Revocable Trust acquired 49,506 shares of the stock in a transaction dated Monday, November 18th. The shares were bought at an average cost of $12.24 per share, with a total value of $605,953.44. Following the transaction, the insider now directly owns 898,584 shares of the company’s stock, valued at $10,998,668.16. This represents a 5.83 % increase in their ownership of the stock. The disclosure for this purchase can be found here . Insiders purchased a total of 203,750 shares of company stock valued at $2,370,418 in the last ninety days. 39.60% of the stock is owned by insiders. Heartland Express Profile ( Free Report ) Heartland Express, Inc, together with its subsidiaries, operates as a short-to-medium, and long-haul truckload carrier in the United States and Canada. It primarily provides nationwide asset-based dry van truckload service for shippers; cross-border freight and other transportation services; and temperature-controlled truckload services. Featured Stories Want to see what other hedge funds are holding HTLD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heartland Express, Inc. ( NASDAQ:HTLD – Free Report ). Receive News & Ratings for Heartland Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartland Express and related companies with MarketBeat.com's FREE daily email newsletter .
Holy Cross secures 82-46 victory over Regis (MA)Unlike thousands of people who scrambled for the drugs Ozempic and Wegovy to lose weight, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It's a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It's all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person's response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss , as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are typically prescribed along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn't happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It's not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn't respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I'm hoping it's slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.”
L ocals are being urged to deepen their understanding of Barbados’ rich history and heritage. During a media briefing at the annual Genealogy Marketplace, Chief Archivist in the Barbados Archives Department, Ingrid Thompson, called on Barbadians to engage with the country’s historical resources. “Come into the archives and peruse the documents, analyse the documents, and get to know the true history of Barbados and what a wonderful country we have,” she said. “We want to bring back that pride in terms of our national identity, who we are as Bajans and what we stand for, what our ancestors went through to bring us to this point, and hope that the current generation and future generations will carry on the traditions and build upon that foundation.” During Saturday’s event Barbadian culture and heritage was celebrated through food, games and documentaries. Thompson noted, “We are encouraging persons to start and get to know how to trace their family history.” You Might Be Interested In Crystal Beckles-Holder, 2nd runner up in regional competition Business owners disappointed Police investigate shooting She highlighted that this year’s exhibit was dedicated to honouring the legacy of Shirley Chisholm as part of the ongoing celebrations of her 100th birthday on November 30. Centred on showcasing a timeline of her life, her interest in Pan-Africanism, her upbringing in Barbados, and her trailblazing journey in the U.S. Congress. Chairman of the centennial celebrations Rodney Grant emphasised the significance of familiarising people with her accomplishments. “We felt that it was necessary for us to reintroduce Shirley to Barbadian people since they would not have known her that well,” he explained. The celebrations have included heritage tours highlighting sites from her upbringing, school visits, and a national art competition offering a trip to New York as a grand prize to explore landmarks associated with her legacy. The awarding winning Christ Church Foundation Steel Orchestra. Grant emphasised Chisholm’s resilience in the face of adversity. “She would have stood up against all of those challenges and would determine that she would have still run for Congress and then after that vote for the president.” The celebrations will continue on Independence Day, with the distribution of paraphernalia to further acquaint Barbadians with her life and values. Describing the exhibit in her honour Norma Springer, Assistant Curator said, “What we have tried to do is to create a multimedia interactive exhibition, so there is the general information on the walls that people can interact with, we have some artefacts including a trunk.” Being innovative, they have used some AI (Artificial Intelligence) technology to generate an aged progression to show what she would have looked like at 100 years old. “We also have the Great Debate, which is a takeaway pamphlet that visitors can have a better appreciation of her thought process,” she noted. Works featured include a powerful piece by spoken word poet Cyndi Celeste and Doreen Beatrice Edwards decorated cigar boxes paying homage to Chrisholm who did the same to raise funds. The event, staged in collaboration with Barbados Tourism Marketing Inc. (BTMI), ties into the broader vision of heritage tourism. Madge Dalrymple, Destination Manager with BTMI, expressed excitement about the initiative. “It is all in a quest to build out the Genealogy Tourism niche,” she explained, adding, “We think that it is very important for persons to know their roots, know where they come from.” She encouraged members of the diaspora to return to the island, noting, “We are excited to be involved in We Gatherin’ next year.” (STT)Carter's single White House term still stirs controversy after more than 40 years
